COVID VACCINES - NO APPOINTMENT NEEDED!
WALK-IN'S WELCOME FOR ALL VACCINATIONS
WE ARE APICK UP AND DROP OFF CENTER.... PACK AND SHIP TODAY!

Get Healthy!

Results for search "Survival".

Health News Results - 162

Fertility preservation procedures for women with breast cancer won't raise the risk of their cancer returning later, a new Swedish study shows.

Women who had eggs or embryos frozen before going through chemotherapy did not have any increased risk of cancer recurrence or de...

Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds.

The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Keytruda (pembrolizumab) is already approved in the Un...

Hormone replacement therapy (HRT) for breast cancer survivors doesn't appear to increase the risk of cancer recurrence or death, Danish researchers report.

Although HRT has previously been linked to a rais...

Getting a blood cancer diagnosis is devastating for young people, but it is also far more deadly if the patient is Black, new research shows.

The new study, which looked at outcomes for patients with acute myeloid leukemia (AML), highlights an urgent need to understand racial and ethn...

Breast cancer survivors who would like to have a baby can take some reassurance from a new study that finds motherhood doesn't lower their future survival chances.

Moreover, survival rates were no worse in younger women, those who had not been pregnant before or those with

  • By Cara Murez HealthDay Reporter
  • |
  • July 7, 2022
  • |
  • Full Page
  • COVID vaccination is highly protective against severe disease in people of all body weights, new British research finds.

    The study of over 9 million adults found that those who'd received two doses of a COVID-19 vaccine were strongly protected against hospitalization or death from the disease. And the effectiveness was just as great for obese people as those with a healthy weight.

    T...

    More than 18 million Americans have now survived cancer, a new report shows.

    The American Cancer Society (ACS) and the U.S. National Cancer Institute collaborated on the report to estimate cancer prevalence and help public health officials better serve survivors.

    "As the popula...

    U.S. veterans are at higher risk for melanoma, the deadliest form of skin cancer, than most Americans, and new research finds they are also more likely to have advanced-stage disease when it's detected.

    At the time of diagnosis, "we found veterans with melanoma were more like...

    A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it.

    All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimab - an anti-PD-...

    The United States spends far more on cancer care than other wealthy nations, but it's not seeing a return on that investment in terms of lives saved, a new study shows.

    Compared with the average high-income country, researchers found the U.S. spends twice as much on cancer care -- more tha...

    Racial disparities in health outcomes persist in the United States, with Black and Hispanic Americans more likely to die within a month after a bleeding stroke than white Americans, a new study shows.

    "We've known that there are disparities in death from stroke among racial and ethnic groups in the U.S. due to

  • By Robert Preidt HealthDay Reporter
  • |
  • June 2, 2022
  • |
  • Full Page
  • Race and ethnicity matter when battling colon cancer, with young white patients facing notably better odds than Black, Hispanic or Asian patients, new research warns.

    A look at colon cancer survival among Americans younger than 50 turned up a glaring discrepancy: Survival five years after diagnosis improved to nearly 70% among white patients over two decades, but was less than 58% among B...

    If you're poor and have a severe type of heart attack, the chance you'll live through it is significantly lower than that of someone with more money, new research shows.

    The finding underscores the need to close a divide in health care that hits low-income people hard, said lead researcher Dr. Abdul...

    Cancer survival rates rose more in states that expanded Medicaid under Obamacare than in those that did not, and rates increased most among Black patients and those in rural areas, according to a new study.

    "Our findings provide further evidence of ...

    Leukemia at a young age is likely to affect survivors' longevity, a new study cautions.

    Even when they're cured, teen and young adult survivors of leukemia have shorter life spans than those who've never had a blood cancer, researchers at the University of Texas MD Anderson Cancer Center found.

    "We need to think about the long-term life span and the quality of life for our patients....

    Long-term survival after a heart attack has improved significantly overall among Medicare beneficiaries, although poorer people and Black Americans have been left behind, a new study claims.

    "Our results demonstrate some accomplishments and some work ahead; we are making progress on improving long-term outcome...

    Survivors of teen and young-adult cancers may feel they've dodged a bullet, but they're not totally in the clear. A new study reveals a high risk of developing and dying from new cancers later on.

    These young people require close monitoring, according to researchers at the American Cancer Society.

    "The risk of subsequent primary cancer among cancer survivors has been extensively stu...

    In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women's Hospital in Boston said Wednesday that its transplant policies mirror those used across the United States.

    In a crowdfunding appeal for 31-year-old D.J. Ferguson, a father of two, his family said the hospital told him he was ineligible to receive a new ...

    COVID-19 is changing medicine in yet another way: A new study finds that patients with COVID-related lung damage now account for nearly one in 10 lung transplants in the United States.

    The researchers analyzed data on more than 3,000 lung transplants nationwide between Aug. 1, 2020, and Sept. 30, 2021. They found that 7% of them were performed to treat severe, irreversible lung damage cau...

    People hospitalized for COVID-19 are not necessarily out of the woods once they're discharged: Many land in the hospital again in the months afterward, a large U.K. study finds.

    The researchers found that in the 10 months after leaving the hospital, COVID-19 patients were more than twice as likely to be hospitalized or die, compared to the general population. And even compared with people...

    Your heart is in an incredibly vulnerable state if you've suffered a heart attack or are fighting heart failure, and cardiac rehabilitation could be an important part of your recovery.

    Unfortunately, not enough older folks appear to be taking advantage of this life-saving therapy.

    Fewer than one in 10 eligible Medicare beneficiaries get recommended heart failure rehab treatments, th...

    The chance of someone who is covered by Medicaid surviving cancer may depend in part on where they live, a new analysis finds.

    In states that had lower Medicaid income eligibility limits, cancer survival rates were worse for cancers both in early and late stages compared to states with higher Medicaid income eligibility limits, Amer...

    Swapping out the butter or other artery-clogging fats in your diet for heart-healthy olive oil may add years to your life, researchers say.

    Folks who consume more than 1/2 a tablespoon of olive oil a day are less likely to die from heart disease, cancer, neurodegenerative diseases like Alzheimer's or lung disease when compared to people who consume less of this

  • Denise Mann HealthDay Reporter
  • |
  • January 11, 2022
  • |
  • Full Page
  • Beating cancer is a huge feat, but how survivors live their lives afterwards also influences their longevity. A new study shows those who sit too much and are not physically active are much more likely to die early from cancer or any other cause than those who are more active.

    Data on c...

    For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found.

    The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), is already standard for advanced melanoma; the other, relatlimab, is not yet approved.

    But b...

    For smokers, new research suggests it really is never too late to quit.

    The study found that folks who kick their habit after a lung cancer diagnosis will likely live longer than those who continue lighting up.

    Investigators from Italy concluded that lung cancer patients who stop smoking at or around the time of their diagnosis can look forward to survival times nearly a third (29%...

    Cancer remains a major killer, with 10 million deaths reported worldwide in 2019.

    More than 23 million new cases were documented globally in 2019, according to researchers at the University of Washington School of Medicine.

    By comparison, in 2010 there were 8.29 million cancer deaths worldwide and fewer than 19 million new cases. Deaths were nearly 21% higher in 2019 than 2010, and...

    For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy.

    The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of the d...

    Women are two times more likely than men to die after receiving a combination of cancer immunotherapy drugs called checkpoint inhibitors, but it's not clear if that difference is due to side effects or because the treatment isn't working, researchers say.

    This new class of highly targeted drugs -- which includes pembrolizumab (Keytruda), nivolumab (Opdivo) or ipilimumab (Yervoy) -- has re...

    People who recovered from a severe case of COVID-19 may have more to worry about: New research finds that patients hospitalized with COVID are 2.5 times more likely to die within the year than people who never contracted the coronavirus.

    They also are nearly twice as likely to die as people who had a mild case of COVID, researchers say.

    The risk of death is even higher for hosp...

    Lung cancer survival rates in the United States continue to rise, but certain racial groups are still hit hard by the disease, the American Lung Association reports.

    Its fourth annual "State of Lung Cancer" report shows that the average five-year survival rate increased from 14.5% to nearly 24%, but it remains at 20% for people of color overall, and 18% for Black Americans.

    "The rep...

    Since 1971, when the U.S. government made defeating cancer a goal and put major funding behind it, death rates for many cancers have plummeted, but some are increasing, according to a new American Cancer Society report.

    Death rates for all cancers combined have declined since passage of the National Cancer Act of 1971, according to the report. For example, in 2019, deaths from lung c...

    Bypass surgery is slightly better overall than stenting to open blocked arteries in people with severe coronary artery disease, new research shows.

    But decisions may still need to be made on a case-by-case basis: Stenting appeared more beneficial in some patients, particularly if they didn't have complex disease.

    The findings should help guide decisions about which treatment is best...

    Mike Smith is beating the odds.

    Diagnosed with stage 4 lung cancer back in 2016, the 56-year-old South Carolina resident says there are a lot of reasons to be optimistic as the "narrative of lung cancer changes from being a horrific, terminal disease to a chronic disease and, ultimately, to a cure."

    Still, he remains clear-eyed about the challenges he faces.

    "I'm at war," he s...

    Younger patients with advanced colon cancer don't live longer than older patients, but it's unclear why, researchers say.

    The authors of the new study said they were surprised by the findings, which come as colon cancer rates are on the rise among young Americans.

    "As a group, younger patients are more physically active and have higher performance status and are better able to perfo...

    Survivors of spinal cord injuries who develop resilience are able to adapt and thrive despite the challenges, according to a researcher who himself is a resilient survivor.

    "For someone with a cord injury, your margin for surviving even small mistakes when it comes to your health is really thin," said James Krause, professor and associate dean for research in the Medical University of Sou...

    Adult staff in schools are more likely than students to suffer sudden cardiac arrest, but automated external defibrillators (AEDs) are often used and improve the chances of survival, a new study finds.

    AEDs are portable devices that deliver an electric shock to try and restart the heart. If appropriate action isn't taken immediately, cardiac arrest is often fatal.

    "Most research on ...

    Long-term symptoms of coronavirus infection, known as 'long COVID,' affects more than half of COVID-19 survivors, and health care systems should be prepared to treat them, researchers say.

    So far, 236 million people worldwide have been diagnosed with COVID-19, and many have had lingering physical and mental health problems for six months or longer.

    "The burden of poor health in COV...

    The ongoing coronavirus pandemic has hit minority groups in the United States hard, with significantly more deaths among Black and Hispanic Americans compared with white and Asian Americans, a new study finds.

    According to the report, these disparities highlight the need to address ongoing inequities influencing health and longevity in the United States.

    What's more, "focusing on CO...

    Black kids and Hispanic kids with cancer fare worse than their white counterparts, a large, nationwide study finds.

    "This study suggests that improving health insurance coverage and access to care for children, especially those with low [socioeconomic status], may reduce racial/ethnic survival disparities," Jingxuan Zhao, an associate scientist at the American Cancer Society in Atlanta, a...

    The size and shape of the blood vessels in your brain may help predict your risk of an often-fatal type of stroke, called an aneurysm, a new study finds.

    An aneurysm is a bulge in an artery wall.

    "A subarachnoid hemorrhage is the most dangerous type of stroke and occurs when a brain aneurysm leaks or ruptures, causing bleeding into the brain, killing more than 50% of affected people...

    If you have a cardiac arrest, your odds of survival are best in an airport or airplane, a new study finds.

    That's because automated external defibrillators (AEDs) are readily available and so are people ready to help, researchers explained.

    "Our findings emphasize that cardiac arrest in travelers is survivable and that early resuscitation interventions matter," said lead researcher ...

    Multiple sclerosis (MS) patients diagnosed with colon cancer may have a greater risk of dying from cancer or other causes in the next six months to year than colon cancer patients without MS, a Canadian study finds.

    "These results warrant further investigation to determine what factors may lead to shorter survival times," said study author Dr. Ruth Ann Marrie, a professor of neurology at ...

    One out of every 500 U.S. residents has lost their lives to COVID-19 since the start of the pandemic last year, statistics show.

    COVID has killed more than 664,500 people in the United States as of Wednesday, according to tracking data from Johns Hopkins University.

    That's out of a total U.S. population of 331.4 million cited by the U.S. Census Bureau.

    The risk of dying from C...

    Older adults who are socially isolated are more likely to experience serious disability or die after a stay in the intensive care unit (ICU), new research reveals.

    "This important research finding sheds light on a crucial health care issue that has become more dire during the COVID-19 pandemic," said Dr. E. Albert Reece, dean of the University of Maryland School of Medicine, in Baltimore....

    The latest buzz on coffee? It may be good for your heart, a new, large study suggests.

    Drinking light to moderate amounts -- up to three cups a day -- may lower the risk of stroke, fatal heart disease and all-cause death, researchers found.

    "Regular coffee consumption of up to three cups per day is associated with a lower risk of all-cause mortality, cardiovascular mortality and str...

    Malignant brain tumor rates are declining among U.S. adults, but patients still have a low chance of survival, a new study finds.

    The researchers also found that rates of noncancerous tumors are on the rise, likely due to increased awareness and improvements in diagnosis.

    "Although the molecular understanding of how brain cancers differ from each other is advancing rapidly, we conti...

    Survivors of severe or long COVID-19 could have greater antibody protection against future infection than those whose illness was shorter or milder, new research suggests.

    For the study, a Rutgers University team followed 548 health care workers and 283 other workers from the start of the pandemic. Within six months, 93 (11%) of them tested positive for SARS-CoV-2 or for antibodies agains...

    If you suffered a bout of COVID-19 and your lungs took a beating, new research has reassuring news: You will likely be spared long-term respiratory damage.

    Scientists looked at COVID-19 survivors who had asymptomatic, moderate or severe COVID-19 infections and also underwent unrelated elective lung operations (for example, to treat lung nodules or lung cancer) at some point after they rec...

    There's strong evidence that the steroid drug dexamethasone can significantly lower hospitalized patients' risk of dying from COVID-19, but many who might benefit from it the most aren't getting it.

    "Dexamethasone is a steroid that is used for the treatment of arthritis, inflammation and allergic reactions," explained Hemalkumar Mehta, who studied its use in treating COVID-19 patients. He...